Headshot of Peter Carlson

Undergraduate education

University of Washington - BS (2012)

Years in MSTP 


PhD program

Cellular and Molecular Biology


Paul Sondel, MD, PhD

Research interest

Studying how distant sites of metastatic disease can oppose immune activation at an in situ vaccine treated site, and how we can better overcome this phenomenon using molecular targeted radionuclide therapy.

Undergraduate and/or masters publications

Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael L, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. Tumor-specific inhibition of in situ vaccination by distant untreated tumor sites. Cancer Immunol Res. 2018 Jul;6(7):825-834 PMID: 29748391; PMCID: PMC6030484.

Shi J, Johnson RN, Schellinger JG, Carlson PM, Pun SH. Reducible HPMA-co-oligolysine copolymers for nucleic acid delivery. Int J Pharm. 2012 May 1;427(1):113-22. PMID: 21893178; PMCID: PMC3240689.

Johnson RN, Chu DS, Shi J, Schellinger JG, Carlson PM, Pun SH. HPMA-oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight. J Control Release. 2011 Oct 30;155(2):303-11. PMID: 21782863; PMCID: PMC3196034.

Carlson PM, Schellinger JG, Pahang JA, Johnson RN, Pun SH. Comparative study of guanidine-based and lysine-based brush copolymers for plasmid delivery. Biomater Sci. 2013 Jul 1;1(7):736-744. PMID: 23750319; PMCID: PMC3673726.